Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of ... - MarketWatch

SmartAboutHealth

Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of ... MarketWatch - Nov 19, 2008 ... combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer (NSCLC) has been temporarily suspended ... Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of ... International Business Times all 46 news articles

Infinity Announces Global Strategic Alliance With Purdue Pharma ... - MarketWatch

Infinity Announces Global Strategic Alliance With Purdue Pharma ... MarketWatch - 14 hours ago Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for ...

Antisoma AGM update and Interim Management Statement - FOXBusiness

Antisoma AGM update and Interim Management Statement FOXBusiness - Nov 18, 2008 A 1200-patient phase III trial (ATTRACT-1) is testing the drug as a first-line treatment for non-small cell lung cancer. This is the setting in which we ... Antisoma AGM update and Interim Management Statement International Business Times all 33 news articles

Celprogen Introduces an in vivo Model for Human Brain Cancer ... - MarketWatch

Celprogen Introduces an in vivo Model for Human Brain Cancer ... MarketWatch - Nov 17, 2008 The other in vivo cancer model systems in the pipe line at Celprogen are: breast cancer, prostate cancer, liver cancer, colon cancer, lung cancer and ...

Danville Weekly Online Calendar - Danville Weekly

Danville Weekly Online Calendar Danville Weekly, CA - 17 hours ago ... for all types of cancer patients as well as cancer specific groups for breast cancer, colorectal cancer, ovarian cancer, lung cancer, prostate cancer, ...